Clinical Cases

Individualised Homeopathic Therapy in ANCA Negative Rapidly Progressive Necrotising Crescentic Glomerulonephritis with Severe Renal Insufficiency – A Case Report

A case of a 60-year-old woman treated with classical homeopathy for ANCA-negative Anti-Neutrophil Cytoplasmic Antibody (ANCA) rapidly progressive Glomerulonephritis (RPGN).

Reprinted from: J Med Life. 2019 Jan-Mar; 12(1): 49–55.  doi: 10.25122/jml-2019-0001 PMCID: PMC6527409 PMID: 31123525

This article is distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use and redistribution provided that the original author and source are credited.


Anti-Neutrophil Cytoplasmic Antibody (ANCA)-negative Rapidly Progressive Glomerulonephritis (Homeopathy Treatment for Glomerulonephritis) (RPGN) is a severe form of autoimmune renal injury with a bleak prognosis.  A 60-year-old Indian woman was treated with classical homeopathy for ANCA-negative RPGN, and after one year of treatment, serum creatinine and other parameters indicating renal injury dropped steadily despite the withdrawal of immunosuppressive drugs; renal dialysis, which was conducted twice a week initially, was made rarer and stopped after one year.

Classical homeopathy may be considered a potential therapeutic modality in severe pathologies. Controlled studies are required to establish further the extent to which classical homeopathy may relieve patients from procedures such as dialysis that cause considerable physical and economic discomfort.

Keywords: ANCA-negative, Dialysis free, Chronic renal insufficiency, Glomerulonephritis, Homeopathy

Keywords: RPGN: Rapidly Progressing Glomerulonephritis, GFR: Glomerular Filtration Rate, ANCA: Anti-Neutrophil Cytoplasmic Antibody, AAV: ANCA-Associated Vasculitis, BVAS: Birmingham Vasculitis (Homeopathy for Vasculitis) Score, CGN: Crescentic Glomerulonephritis, pANCA: Peripheral ANCA, cANCA: Cytoplasmic ANCA


Crescentic Glomerulonephritis (CGN) causes loss of renal function rapidly through cellular proliferation within Bowman’s space and formation of crescents. CGN is further differentiated on the presence of glomerular deposition of immune complexes seen on immunofluorescence. However, the majority of the CGN is pauci-immune, exhibiting no such deposits. These are termed ANCA-associated vasculitis (AAV) as these exhibit renal small-vessel vasculitis [1].

ANCA-negative RPGN is a diagnostic category of AAV that has not been studied as exhaustively as the ANCA-positive cases. Only 10-15% of the pauci-immune RPGN cases are ANCA-negative [2], and it affects younger people with very little extrarenal involvement when compared to the ANCA-positive. The renal damage is much higher and the prognosis poorer. Though mortality is not different from the positive cases, the dependency on dialysis is higher, and the renal improvement with immunosuppression or plasmapheresis is minimal [3, 4].

In these cases, though histologically renal damage may be extensive, the renal outcome after treatment is more significantly related to the serum creatinine at first consultation, and those with severe renal disease remained dialysis dependent [1–10]. Studies have shown renal outcome to be poor in ANCA-negative cases with very less probability for becoming dialysis-free [4, 11]. The negative prognostic factors for the renal outcome for CGN in general are: Glomerular Filtration Rate (GFR) <15 mL/min, advancing age, higher Birmingham Vasculitis Activity Score (BVAS), low hemoglobin and higher WBC count [1].

Immunosuppressive drugs such as cyclophosphamide prescribed in these cases have their risks associated and may be the cause for the increased mortality in older patients with ANCA-negative RPGN, due to cardiovascular diseases and infectious complications associated with immunosuppression [7].

The following case was diagnosed with ANCA-negative RPGN with severe renal insufficiency and underwent conventional treatment for 4 months with immunosuppressive drugs, dialysis, and plasmapheresis. The patient was receiving dialysis twice a week at the time of the homeopathic consultation, with high serum creatinine and low hemoglobin. The evolution of the case under homeopathic treatment is presented here. To the best of our knowledge, this is the first case report of this diagnosis under homeopathic treatment.

Case Presentation

A 60-year-old Indian woman was diagnosed with rapidly progressing necrotizing crescentic glomerulonephritis with severe renal insufficiency in March 2015 (Table 1). She presented with a serum creatinine of 4.8 mg/dl, hematuria and albuminuria (GFR 9 mL/min/1.73 m2).On immunofluorescence testing, she was weakly positive for Anti Nuclear Antibodies but negative for both pANCA and cANCA. The lactate dehydrogenase, depicting the extent of tissue damage, was very high (404 IU/L; Normal: 103 – 227 IU/L). BVAS was estimated to be 14.

Table 1:

Laboratory findings at the moment of diagnosis (09/03/2015) and medication before homeopathic therapy

Test Patient value Normal range List of medications the patient was on, with content
RBC count 2.78 X 106/cumm 3.5 – 5.5 X106/cmm Auxisoda (Sodium bi carbonate)
Hemoglobin 8.7 g% 11 to 16 g% Calcigard (Nifedipine)
Blood urea 134.7 mg/dl 15 – 45 mg/dl Alprax (Alprazolam)
Serum creatinine 4.8 mg/dl 0.6 – 1.4 mg/dl Aciloc (rantidine)
Estimated GFR 9 mL/min/1.73 m2 > 60 mL/min/1.73 m2 Ondem (Ondansteron)
Estimated BVAS 14 NA Frusenex (Furosemide)
Serum albumin 3.0 g/dl 3.2 – 4.6 g/dl Metoz (Metolazone)
Serum globulin 2.1 g/dl 2.3 – 3.5 g/dl Aldactone (Spironolactone)
Total serum proteins 5.1 g/dl 6 – 7.8 g/dl Omnacortil (Prednisolone)
Lactose dehydrogenase 404.4 IU/L 103 – 227 IU/L Endoxan (Cyclophosphamide)
Reticulocyte count 4% 0.2 – 2 % Dargen (Darbepoetin)
Antinuclear Antibody weakly +ve -ve Vozuca (Voglibose)
pANCA -ve NA Linid (Linezolid)
cANCA -ve NA Cardivas (Carvedilol)
Urine albumin 2+ nil Ciplox (Ciprofloxacin)
Urine RBC 35 – 40 hpf nil
Urine Protein to Creatinine Ratio 2.64 <0.5
Abdominal and pelvic ultrasound scans Bilateral medical renal disease (Grade II) NA

She underwent conventional medical treatment until July. Initially, she received glucocorticoid and cyclophosphamide (immunosuppressive drugs) which did not control the serum creatinine. She then had to undergo plasmapheresis (5 sessions) and dialysis once a week. Despite this, the serum creatinine rose again, and the dialysis was increased to twice a week. However, there was no effective control of serum creatinine.

On 2/07/2015, with dialysis twice a week and immunosuppressive drugs, the serum creatinine was 5.2 mg/dl (normal is up to 1.4 mg/dl), GFR was 8 mL/min/1.73 m2, and hemoglobin was 8.7 g% (with a bone marrow-stimulating injection given periodically). The patient was already developing constitutional symptoms due to the immunosuppressive drugs, with weakness, loss of appetite, weight loss, pigmentation of skin and nails and shortness of breath. The BVAS (worsening) at this point worked out to be 15.

 Homeopathic intervention

The patient sought homeopathic treatment on 16/07/2015. The homeopathic case-taking involves an exhaustive recording of the patient’s past medical history, treatment history and also significant events that may have had a stressful effect along with the familial medical history. The intention is to arrive at the factors that have undermined the defense mechanism of the organism. In this case, the patient related that she started having problems 5 months earlier after severe stress from the illness of her mother. It began as edema, and she was diagnosed with ANCA RPGN.

In the past, she had developed a severe form of skin eruptions which were treated conventionally. She had undergone ozone therapy for arthritis of the knee a year and a half earlier. Family history revealed that her paternal grandfather and father had both died of cancer.

Homeopathic therapy was begun after considering all these factors and the individual symptomatology. The immunosuppressive drugs were stopped from the first day of homeopathic consultation, and the steroidal drugs were tapered slowly and completely stopped within one and a half months after starting homeopathic therapy.

 Outcome and follow-up

The patient steadily improved in terms of general condition (energy, appetite, weight and so forth) as well as blood reports (Table 2). As a result, she was able to increase the gap between consecutive dialysis sessions slowly, and eventually stop it in August 2016. Over the 28-month follow-up period, the patient was in a generally well-preserved condition with steady improvement in renal function.

Table 2:

Evolution under homeopathic therapy

Date Lab reports Symptoms Remedy Changes in conventional interventions
16/07/2015 Serum creatinine: 5.2 mg/dl Severe weakness
Lost appetite
Black discoloration of nails and skin since starting conventional treatment
Face edema
Weight loss in one year
Carcinosinum 30C, raised to 32C after one week and 33C after the next 10 days Dialysis reduced to once a week;
Withdrawal of immunosuppressive drugs
27/08/2015 Serum creatinine: 6 mg/dl
(initial response to medicine brought about encouraging results, so the dialysis was postponed a little resulting in the temporary rise)
Hb: 11.3 g%
Much more energy
Black discoloration of nails and skin reduced considerably
Increased urine output
Stop carcinosinum and wait Steroids slowly tapered
30/09/2015 Serum creatinine: 5.14 mg/dl
Blood pressure: 110/70mm Hg
Gained 2 kg
Appetite improved
Nil Withdrawal of antihypertensives
25/11/2015 Serum creatinine: 6.5 mg/dl Generally very well Nil Is on dialysis once in 10 days, advised to continue the same
20/01/2016 Serum creatinine: 4.3 mg/dl Gained 3.5 kg
Improved energy and appetite
Eruptions appeared on the left elbow (had them in the past)
Nil Dialysis reduced to once a fortnight
17/02/2016 Serum creatinine: 5.5 mg/dl Generally in good condition Nil Dialysis reduced to once a fortnight
17/03/2016 Serum creatinine: 5.6 mg/dl Emotionally stressed after her mother died
Developed acute lower respiratory tract infection – rattling cough, dyspnea, low appetite and energy
Ammoniacum gummi 30C Nil
13/04/2016 Serum creatinine: 4.7 mg/dl Generally very well Nil Nil
04/05/2016 Serum creatinine: 5.6 mg/dl
Blood urea: 95.5 mg/dl
Low appetite for 15 days with nausea
Weight reduced 1 kg
Leg cramps
Disturbed sleep
Occasional loose stools
Sulphur 200C Nil
01/06/2016 Serum creatinine: 4.9 mg/dl Nausea absence
Increased appetite
More energy
No loose stools
No leg cramps
Better sleep
Nil Nil
29/06/2016 Serum creatinine: 4.7 mg/dl Generally very well
Increased skin eruptions on the elbow
Dry skin, itching eczema on the right hand and knuckles
Nil Increased gap between dialysis
(one year after beginning homeopathy)
Serum creatinine: 4.5 mg/dl
RBC: 3.72X106/cmm
Hb: 11.6 g%
Weight increased by 2 kg
Improved energy and appetite
Eruptions increasing
Nil Nil
29/09/2016 Serum creatinine: 3.7 mg/dl Had fever for 2 days
Improved energy
Feels like before the onset of the disease
Skin eruptions still increasing on the knees
Nil Last dialysis on 24/08/2016 – AV fistula closed by accident and the patient did not return voluntarily for dialysis
Took two paracetamol tablets in between for a mild fever
01/12/2016 Serum creatinine: 3.4 mg/dl
Hb: 11.2 G%
RBC: 3.56X106/cmm
SPO2: 97%
Urine albumin ++
Nephrology assessment:
Edema – nil
Dyspnea – nil
Appetite – good
Urine – normal
CVS/CNS – normal
Blood pressure: 130/80 mm Hg
Nil No dialysis for 3 months
16/05/2017 Serum creatinine: 3 mg/dl
Hb: 10.9 g%
Urine albumin: traces
Generally very well
Skin eruptions are reducing
Nil Nil
03/11/2017 Serum creatinine: 2.7 mg/dl Reduced skin eruptions Nil Nil
No dialysis since 14.5 months

The latest serum creatinine is 2.6 mg/dl, hemoglobin is 11.9g%, and the BVAS is estimated to be 4 and GFR is 19 mL/min/1.73 m2. The patient continues homeopathic therapy.


Renal dialysis is a considerably stressful procedure for patients, and it can be economically draining as well. It also carries the risk of various infections and iatrogenic complications [12, 13]. In severely affected RPGN, there is little else that can help alleviate the disease (except renal transplant), and the patient needs to undergo this cumbersome procedure regularly [6]. In the case of this 60-year-old patient, renal dialysis was altogether dispensed with, and the renal function was also restored to a certain extent in 28 months of follow-up.

The homeopathic perspective of a disease is holistic. It considers the whole process of inflammatory changes that have occurred from birth to the given point in time. ‘The Continuum of a Unified Theory of Diseases’ propounds the idea that all the pathological processes in a person from the time of birth to death form a continuum and are not incidental [14]. Initially, when the immune system is in a good state, it successfully mounts acute inflammation and drives away the pathogenic stimulus. When continuously thwarted through anti-inflammatory drugs or other substances that hinder inflammation, it loses the ability to react through strong inflammation and enters a state of chronic low-grade inflammation, eventually turning on the chronic disease that one is predisposed to. At such a stage, homeopathic therapy has been shown to reverse this situation, and as the chronic problem becomes simplified, the person begins to have acute diseases again [15–17]. Also, if any superficial inflammatory disease was suppressed through medication, at this point it returns, and such a return is a further confirmation of the immune system reverting to its previous state.

In this case, the patient had an episode of respiratory infection as the renal function started to improve, which was also treated by homeopathy. Further, she developed skin eruptions again, similar to what she had many years ago and was aggressively treated then. This time, the condition responded very well to the ongoing homeopathic treatment, and the eruptions have become less aggressive.

This rule of return of old suppressed conditions and onset of acute diseases as the chronic one becomes better is used as a guide by the homeopathic therapist to decide the direction the case is taking and to understand the prognosis in a given case [18, 19]. As it happens, in this case, the outcome was very good.

Onset and progress of the skin lesions during homeopathic therapy

The effect of homeopathic therapy is evident also in terms of pathology as is evidenced by the improvement of GFR from 8 mL/min/1.73 m2 to 19 mL/min/1.73 m2 and BVAS from 15 to 4.

The immunosuppressive drugs were stopped early on during homeopathic therapy resulting in elevated serum creatinine indicating the effect of immunosuppression withdrawal. However, this gradually responded to homeopathic therapy, and the patient was able to stop dialysis. The patient has remained free of drugs and dialysis for 20 months now, with steady improvement in renal function. This is reasonable grounds to plan more extensive controlled studies in the future.

Severe disorders and autoimmune conditions have been shown to respond to homeopathic therapy before now, and this case also indicates a possibility for this therapy [20–24]. There is a selection bias in this case as the patient opted for the treatment and the response was good. A controlled study will help establish the exact extent to which homeopathy may be of help and in this kind of cases.


Even this rare case report of ANCA-negative RPGN showed a positive response to individualized homeopathic therapy while having poor prognosis conventionally. This suggests that RPGN may be amenable to individualized therapy in the early stages. Further, more extensive studies may establish the extent to which homeopathy may be useful in such conditions.


  • – ANCA-negative RPGN is challenging to treat even with immunosuppressive drugs and dialysis.
  • – Further proof for the questionable utility of plasmapheresis in the case of ANCA-negative RPGN.
  • – Classical individualized homeopathic therapy holds some promise in this pathology and needs to be investigated further.
  • – The phenomena of return of acute inflammatory states along with improvement in chronic inflammatory diseases are worth investigating to throw light on the immunological changes involved.

Conflict of Interest

The authors confirm that there are no conflicts of interest.


  1. Moroni G, Ponticelli C. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmunity Reviews. 2014;13(7):723–729.
  2. Peschel A, Basu N, Benharkou A, Brandes R, Brown M, Dieckmann R, et al. Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN. J Am Soc Nephrol. 2013;25:455–63.
  3. Glockner W, Sieberth H, Wichmann H, Backes E, Bambauer R, Boesken W, Bohle A, Daul A, Graben N, Keller F. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clinical Nephrology. 1988;29(1):1–8. [Internet]. [cited 2018 Mar 11]
  4. Sharma A, Nada R, Naidu G, Minz R, Kohli H, Sakhuja V, Gupta K, Rathi M. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? International Journal of Rheumatic Diseases. 2015;19(1):74–81.
  5. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol. 1996;7:2271–8.
  6. Chen M, Kallenberg CGM, Zhao M-H. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5:313–8.
  7. Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, Lesavre P, Noël L. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrology Dialysis Transplantation. 2005;20(7):1392–1399.
  8. Hedger N. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–9.
  9. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–77.
  10. Sampathkumar K, Ramakrishnan M, Sah AK, Gowtham S, Ajeshkumar RN. ANCA negative pauci-immune glomerulonephritis with systemic involvement. Indian J Nephrol. 2010;20:43–47.
  11. Hung P, Chiu Y, Lin W, Chiang W, Chen Y, Lin S, Wu K, Tsai T. Poor Renal Outcome of Antineutrophil Cytoplasmic Antibody Negative Pauci-immune Glomerulonephritis in Taiwanese. Journal of the Formosan Medical Association. 2006;105(10):804–812.
  12. Abram HS, Moore GL, Westervelt FB. Suicidal behavior in chronic dialysis patients. Am J Psychiatry. 1971;127:1199–204.
  13. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68:S7–10.
  14. Vithoulkas G, Carlino S. The “continuum” of a unified theory of diseases. Med Sci Monit. 2010;16(2):SR7–15.
  15. Kivellos S, Skifti S, Vithoulkas G. EHMTI-0396. Reappearance of high fever on migraine patients, after individualized homeopathic treatment, is a valuable prognostic factor. The Journal of Headache and Pain. 2014;15(S1)
  16. Vithoulkas G. Alonissos, Greece: International Academy of Classical Homeopathy; 2017. Levels of health.
  17. Vithoulkas G, Tiller W. Athens: International Academy of Classical Homeopathy; 2009. The science of homeopathy.
  18. Chabanov D, Tsintzas D, Vithoulkas G. Levels of Health Theory With the Example of a Case of Juvenile Rheumatoid Arthritis. Journal of evidence-based integrative medicine. 2018 Jun 11;23 2515690X18777995.
  19. Kivellos S, Skifti S, Vithoulkas G. EHMTI-0396. Reappearance of high fever on migraine patients, after individualized homeopathic treatment, is a valuable prognostic factor. The Journal of Headache and Pain. 2014 Dec;15(1):M7.
  20. Mahesh S, Mallappa M, Vithoulkas G. Embryonal carcinoma with immature teratoma: A homeopathic case report. Complementary Medicine Research. 2018;25(2)
  21. Mahesh S, Mallappa M, Vithoulkas G. Gangrene: five case studies of gangrene, preventing amputation through homoeopathic therapy. Indian Journal of Research in Homoeopathy. 2015;9:114–22.
  22. Mahesh S, Mallappa M, Tsintzas D, Vithoulkas G. Homeopathic Treatment of Vitiligo: A Report of Fourteen Cases. The American Journal of Case Reports. 2017;18:1276.
  23. Mahesh S, Mahesh M, Vithoulkas G. Could Homeopathy Become An Alternative Therapy In Dengue Fever? An example Of 10 Case Studies. Journal of Medicine and Life. 2018 Jan;11(1):75.
  24. Tenzera L, Djindjic B, Mihajlovic-Elez O, Pulparampil BJ, Mahesh S, Vithoulkas G. Improvements in long standing cardiac pathologies by individualized homeopathic remedies: A case series. SAGE open Medical Case Reports. 2018 Aug;6 2050313X18792813.

Articles from Journal of Medicine and Life are provided here courtesy of Carol Davila – University Press

Copyright ©Carol Davila University Press

About the author

Seema Mahesh

Dr Seema Mahesh (BHMS, MD (hom) Dip IACH (Greece), MSc Medical Sciences (Malaysia) is a classical homeopath from Bangalore, India, practicing for the past 20 years. She completed homeopathic medical education at the Rajiv Gandhi University and her PG diploma at the International Academy of Classical Homeopathy (IACH), Greece, under Prof George Vithoulkas. She then turned to research and trained at the Taylor’s University Malaysia for her research post-graduation degree in Medical Sciences. She has been involved in the research committee of IACH and is currently the Director of Research at IACH Greece, collaborating with clinicians and researchers from 95 countries. She is instrumental in taking the core concepts of classical homeopathy to the medical journals and conferences. Having published 22 research papers in peer reviewed medical journals, and hundreds of articles on other platforms, she has also presented her research on concepts of health, disease and cure at medical conferences of immunology and autoimmunity, at NewYork USA, Fiji, Dublin Ireland, Krakow Poland, Stockholm Sweden, Harvard Medical School USA, Amsterdam Netherlands, London UK, Madrid Spain,Vancouver Canada, Tel Aviv Israel, Istanbul Turkey, New Delhi, Athens Greece, Basel, Switzerland and Paris, France. Her presentation at Harvard won her an award of excellence. Her research papers have been downloaded a record number of times.

About the author

Atul Jaggi

Dr. Atul Jaggi is Director of H3 - Health & Happiness by Homeopathy, Centre of Classical Homeopathy, Nashik, Maharashtra, India. Dr. Jaggi came in contact with Homeopathy in 1991 when he started studying from one of India’s best college – Nehru Homeopathic Medical College and Hospital, New Delhi. But his real homeopathic evolution began, when in 1996 he got fortunate to join the first group of Four Year Course in International Academy of Classical Homeopathy (IACH), headed by Prof George Vithoulkas. In 2000, he received the esteemed Diploma of IACH and was awarded with a scholarship, as he stood 3rd amongst 170 International doctors. Since 2016, he is a teaching member at IACH, Greece and he also gives International seminars and Webinars. His main mission is to bring students in contact with the precious and life changing teachings of Prof George Vithoulkas and spread real Hahnemannian Classical Homeopathy.

About the author

George Vithoulkas

George Vithoulkas is an Honorary Professor of the Moscow Medical Academy, Professor in the Kiev Medical Academy, Honorary Professor at the University of the Aegean, Greece, Collaborating Professor in Basque Medical University (2001-2004) and Doctor Honoris Causa of "Doctor ViktorBabes" University of Medicine and Pharmacy of Timisoara in Romania. In 1995, he established International Academy of Classical Homeopathy in Alonissos, of which he is the director. In 1996, he was honored with the Right Livelihood Award (also known as Alternative Nobel Prize) "for his outstanding contribution to the revival of homeopathic knowledge and the training of homeopaths to the highest standards".

1 Comment

Leave a Comment